Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 2011

View Archived Issues

ArQule and Daiichi Sankyo disclose preclinical findings on ARQ-092

New biomarker for dengue fever identified

Acasti Pharma begins second phase II CaPre study

New serine/threonine-protein kinase ATR inhibitors claimed

Second remissions evaluated in epratuzumab study in relapsed acute lymphoblastic leukemia

Paladin Labs launches product for digoxin toxicity and overdose in Canada

New glimepiride formulation launched in Japan

Neoprobe licenses imaging agent from AstraZeneca

Antitumor effects of K-560 evaluated in preclinical settings

Novel antimalarial is potent without inducing parasite dormancy

Researchers at Chemilia design new anticancer agents

New histamine H3 receptor modulators presented

Novel antibacterial and antifungal agents disclosed by A*STAR

Baxter International signs acquisition agreement

Tarsa Therapeutics plans NDA submission for oral recombinant calcitonin

FDA committee issues vote on Adasuve

Japanese phase II/III trial in osteoporosis meets primary endpoint

Simcere and Bristol-Myers Squibb extend partnership

OSI Pharmaceuticals presents new macrophage-stimulating protein receptor inhibitors

Pharmalink in-licenses Archimedes Pharma technology

Treatment begins in pivotal phase III CXA-201 trial

Avila Therapeutics product shows promise to treat hematological cancers

Bayer HealthCare submits applications for long-term contraceptive system

ATx08-001 study meets primary objectives

Zybrestat to be provided on a compassionate-use basis

Veregen mutual recognition approval process continues

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...